menu search

Abbvie raises profit forecast after humira, newer drugs drive results beat

AbbVie on Friday raised its annual profit forecast after beating quarterly earnings estimates, helped by a lower-than-feared drop in sales of its bloc...

October 27, 2023, 7:42 am

Roche settles us patent lawsuit against biogen over blockbuster arthritis drug

Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster rh...

October 23, 2023, 3:28 pm

Global rheumatoid arthritis market poised for us$ 1.2 billion by 2033: growing prevalence of rheumatoid arthritis boosts market growth, according to persistence market research

Key market drivers of Rheumatoid arthritis Market: rising prevalence, increased demand for treatments, ...

October 12, 2023, 12:10 pm

Biogen gets fda approval for biotech treatment similar to roche's actemra

Biogen Inc. BIIB, -0.32% said late Friday the Food and Drug Administration approved its biosimilar version of Roche ROG, +0.30% ‘s ...

September 29, 2023, 4:25 pm

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...

September 28, 2023, 7:18 am

Aofas and the arthritis foundation award grants to fuel ankle arthritis research

Nearly $600,000 in merit-based grants were awarded through The Ankle arthritis Think Tank Research Gran...

September 19, 2023, 7:00 pm

Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations

Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...

August 29, 2023, 7:50 am

Teva pharm ceo: not too late to launch humira biosimilar in 2024

Teva Pharmaceutical Industries , will still pursue launching a biosimilar for arthritis drug Humira nex...

August 2, 2023, 12:26 pm

Abbvie raises annual profit forecast as humira stays strong, new drugs impress

AbbVie on Thursday raised its annual profit forecast after beating analysts' estimates for second-quarter earnings on a lower-than-expected fall in sa...

July 27, 2023, 7:42 am

Abbvie may see less pain from humira sales decline as rival lags

AbbVie Inc is likely to beat Wall Street sales estimates for Humira in the second quarter as the only copycat in the U.S. market for the blockbuster <...

July 26, 2023, 12:07 pm

Abbvie turns to newer immunology drugs as blockbuster humira faces lower-cost competition

As AbbVie Inc. ABBV, -0.63% looks to plug holes in the sales of its mega-blockbuster arthritis drug Hum...

July 25, 2023, 10:41 am

Biosimilar contract manufacturing market size to hit usd 26.1 billion by 2032 at 18.90% cagr – report by market research future (mrfr)

Biosimilar Contract Manufacturing Market Trends and Insights By Product (Recombinant Non-glycosylated Proteins and Recombinant Glycosylated Proteins),...

July 24, 2023, 11:34 am

Kiniksa pharmaceuticals: autoimmune therapy offers attractive prospects at current price

Innovations in the drug lineup, including ARCALYST, KPL-404, and Mavrilimumab, showcase Kiniksa's dedication to targeting challenging autoimmune and i...

July 19, 2023, 3:25 pm

Aclaris therapeutics: q4 of 2023 catalyst makes this a must watch

Aclaris Therapeutics, Inc. results from a phase 2b study using zunsemetinib for the treatment of patients with rheumatoid ...

July 11, 2023, 7:31 pm

: organon and samsung bioepis launch humira biosimilar hadlima in the u.s.

Organon & Co. OGN and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move comes af...

July 5, 2023, 11:39 am

Abbvie braces for increased humira competition from cheaper biosimilar

AbbVie is about to face stiffer competition for its blockbuster rheumatoid arthritis drug Humira from a...

July 5, 2023, 10:14 am

Celltrion launches biosimilar of abbvie's blockbuster drug humira in us

South Korea's Celltrion Healthcare has launched a copycat version to AbbVie Inc's Humira at about a 5% discount, adding to the growing competition for...

July 5, 2023, 7:34 am

Organon and samsung bioepis launch humira biosimilar hadlima in the u.s.

Organon & Co. OGN, -1.15% and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move ...

July 5, 2023, 6:45 am

India's biocon biologics launches biosimilar for abbvie's humira in us

India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid ...

July 3, 2023, 1:59 pm

Fresenius launches biosimilar version of abbvie's humira at 5% discount

The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid ...

July 3, 2023, 10:59 am


Search within

Pages Search Results: